"Drug Smuggler"

A small, publicly traded biotech is working on the discovery of a lifetime:

Using a "drug smuggler" to fight Alzheimer's, Parkinson's and Dementia.

This unconventional treatment is so promising, a Big Pharma giant bought 11.2% of the company.

Click to Read Transcript